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Abstract 
 
Previous work indicates that intranasal inhalation of oxytocin improves face recognition 
skills, raising the possibility that it may be used in security settings. However, it is unclear 
whether oxytocin directly acts upon the core face-processing system itself, or indirectly 
improves face recognition via affective or social salience mechanisms. In a double-blind 
procedure, 60 participants received either an oxytocin or placebo nasal spray before 
completing the One-in-Ten task – a standardized test of unfamiliar face recognition 
containing target-present and target-absent line-ups. Participants in the oxytocin condition 
outperformed those in the placebo condition on target-present trials, yet were more likely to 
make false-positive errors on target-absent trials. Signal detection analyses indicated that 
oxytocin induced a more liberal response bias, rather than increasing accuracy per se. These 
findings support a social salience account of the effects of oxytocin on face recognition, and 
indicate that oxytocin may impede face recognition in certain scenarios. 
 
 
 
Keywords: Oxytocin; face recognition; social salience; eye-witness.  
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Oxytocin increases bias, but not accuracy, in face recognition line-ups 
 
Oxytocin is a nonapeptide that plays a fundamental role in social cognition (Heinrichs, von 
Dawans, & Domes, 2009), and recent evidence demonstrates that intranasal inhalation of the 
hormone improves face-processing. For example, a number of studies have found that people 
are significantly better at recognising facial expressions of emotion following oxytocin 
inhalation (Van Ijzendoorn & Bakermans-Kranenburg, 2012); and there is some evidence that 
oxytocin improves facial identity memory in both typical participants (Guastella, Mitchell, & 
Dadds, 2008; Rimmele et al., 2009; Savaskan et al., 2008) and those with prosopagnosia 
(Bate et al., 2014). However, the benefits of oxytocin for facial identity recognition are 
somewhat inconsistent, with some studies finding effects under limited circumstances (e.g. 
only when the faces show certain emotional expressions, Guastella et al., 2008; Saskavan et 
al., 2008), and others finding selective, null or negative effects (e.g. Bate et al., 2014; 
Herzmann et al., 2012). Understanding the effects of oxytocin on face recognition is an 
important issue: the hormone may be useful for face recognition tasks within security or 
forensic settings, and it is therefore important to clarify when oxytocin does and does not 
benefit face recognition, and the mechanisms that underpin this effect.  
Currently, the mechanisms underpinning the link between oxytocin and improved 
face-processing are unclear. It is possible that oxytocin acts upon visuocognitive mechanisms 
within the core face-processing system (Haxby, Hoffman, & Gobbini, 2000), and some 
neuroimaging evidence supports this possibility (e.g. Domes et al., 2010; Labuschagne et al., 
2010). Alternatively, oxytocin may affect face-processing indirectly by modulating affective 
or social salience mechanisms. The hypothesis that oxytocin increases social salience, either 
via an affective (Shamay-Tsoory et al., 2009; Theodoridou, Penton-Voak, & Rowe, 2013) or 
approach-withdrawal (Ditzen et al., 2009; Kemp & Guastella, 2011) mechanism, is supported 
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by several lines of neuroimaging and behavioural evidence (Bartz et al., 2011; De Dreu et al., 
2010, 2011; Gamer, Zurowski, & Büchel, 2010; Petrovic et al., 2008; Shamay-Tsoory et al., 
2009). Notably, evidence suggests that oxytocin is not always facilitative (e.g. De Dreu et al., 
2011; Parris et al., 2014; Shamay-Tsoory et al., 2009), raising the possibility that it may only 
improve face recognition performance under certain conditions.  
A novel means of exploring this issue is to investigate the influence of oxytocin on 
face recognition within line-up scenarios, where multiple faces are simultaneously displayed 
for recognition and a target face may or may not be present. This manipulation not only 
presents concurrent competing faces to challenge recognition and discrimination abilities (a 
context approximating social settings), but also provides conditions where participants have 
to respond in the negative (target-absent trials) to stimuli whose salience might have 
increased under oxytocin.  
If oxytocin acts upon the face recognition system, performance should improve in 
both target-present and target-absent conditions. Alternatively, given the pro-social effects of 
oxytocin described above, it may influence affective or social salience mechanisms, 
decreasing the likelihood of participants responding in the negative to salient stimuli. This 
would impede performance in target-absent trials due to a greater number of false-positive 
errors. Such findings would have important implications for real-world use of oxytocin, 
particularly if it encourages misidentification. The current study aimed to examine this issue, 
by investigating the influence of oxytocin on a standardized test of unfamiliar face 
recognition consisting of target-present and target-absent line-ups.  
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METHOD 
 
Participants 
Sixty Caucasian participants (35 female; Mean age = 22.8 years, SD = 3.3) were randomly 
assigned in a double-blind between-subjects procedure to receive either oxytocin or placebo 
spray. Gender was approximately dispersed between the conditions, (oxytocin: 19 female; 
placebo: 16 female), χ
2
 = .62, p = .432, and there was no significant difference in age 
between the oxytocin and placebo groups (oxytocin: Mean = 22.9 years, SD = 3.3; placebo: 
Mean = 22.6 years, SD = 3.3), F(1,58) = 0.75, p = .785. As participant race can affect face 
recognition performance (the other-race effect; Tanaka, 2013), only Caucasian participants 
were included in the study. 
 Participant exclusion criteria were pregnancy, medication (with the exception of oral 
contraceptives), significant medical or psychiatric illness, history of substance abuse and 
epilepsy. Participants were instructed to abstain from alcohol, caffeine and nicotine on the 
day of testing, and not to consume any food or drink (other than water) for two hours prior to 
the experiment. Nasal spray administration procedures are described fully in Bate et al. 
(2014). Ethical approval was granted by the departmental ethics committee at Bournemouth 
University, and participants received a small monetary payment in exchange for their time. 
Informed consent was obtained from all participants, according to the Declaration of 
Helsinki. 
 
Stimuli and Materials 
The One-In-Ten test: The face recognition task used in this study was the One-In-Ten test 
(Bruce et al., 1999): a test containing 20 target-present and 20 target-absent trials, that has 
been well-used and validated within the psychological literature (e.g. Bindemann et al., 2012; 
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Megreya & Burton, 2007). In each of the 40 randomly-presented trials, participants study a 
single target face until they are confident they can identity it from a subsequent line-up. 
Target faces are extracted from high-quality video footage, and measure 155 pixels in width 
and 200 pixels in height at a screen resolution of 72 ppi. After the participant presses a key to 
indicate that encoding is complete, the target is instantly replaced by a line-up of ten faces, 
each measuring 132 pixels in width and 200 pixels in height. All faces display a neutral 
expression and are not cropped to exclude the external features, in order to maintain the 
ecological validity of the task.  
Participants are required to use defined keys on the keyboard to indicate which face 
(if any) matches the target face. To encourage maximum performance, no time limits are 
imposed on the participant in any part of this task (see Bruce et al., 1999). For target-present 
trials, participants can make a correct identification (a “hit”), or one of two incorrect 
responses: either a “misidentification” (i.e. the incorrect identification of a distractor face) or 
a “miss” (the incorrect response that a target is absent). In target-absent trials, the correct 
response is referred to as a “correct rejection”, and incorrect responses as “false-positives”. 
 
The Multidimensional Mood Questionnaire (MMQ): General affect was measured throughout 
the experiment using the MMQ (Steyer et al., 1997). This self-report questionnaire is 
composed of three sub-scales (good-bad, awake-tired and calm-nervous), and was used to 
assess the possible mood-altering effects of oxytocin, and to control for non-specific effects 
of attention and wakefulness. 
 
Procedure 
Participants initially received a single intranasal dose of 24 IU of either oxytocin (Syntocinon 
Spray, Novartis) or placebo (identical to the experimental spray with the exception of the 
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oxytocin) spray. Following inhalation, participants sat quietly for 45 minutes before 
completing the One-In-Ten task. This rest period is in line with previous studies of oxytocin 
in face-processing (e.g., Herzmann et al., 2012; Rimmele et al., 2009), and allows sufficient 
time for plasma oxytocin levels to peak after inhalation (Gossen et al., 2012; Striepens et al., 
2013). Each participant was required to complete the MMQ at three intervals across the 
experiment: immediately following inhalation, after the 45-minute resting period, and after 
the One-In-Ten test had been completed. 
 
 
RESULTS 
 
Table 1 shows a summary of the results from the eyewitness task, broken down by gender. 
Initially, all analyses were conducted with gender as a between-subjects variable. However, 
there were no significant main effects or interactions relating to gender (all p’s > .1), so all 
analyses are reported with data collapsed across gender. 
< Insert Table 1 > 
 First, the time taken to encode target faces was examined, and no differences were 
observed between the oxytocin and placebo condition (all ps > .05). Second, we examined 
only the correct responses from the test phase (i.e. the hits and correct rejections). 
Specifically, a 2 (spray: oxytocin, placebo) x 2 (line-up: target-present, target-absent) mixed 
design analysis of variance (ANOVA) revealed no main effect of spray, F(1,58) = .011, p = 
.919, ƞp
2
 = .001. However, there was a significant main effect of line-up, F(1,58) = 9.373, p = 
.003, ƞp
2
 = .139, moderated by a significant interaction between spray and line-up, F(1,58) = 
8.036, p = .006, ƞp
2
 = .122 (see Figure 1). Planned follow-up analyses indicated that this 
interaction was driven by better performance in the oxytocin condition for target-present 
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compared to target-absent trials, but there was no such difference in the placebo condition, 
F(1,29) = 26.573, p = .001, ƞp
2 
= .478 and F(1,29) = .019, p = .891, ƞp
2
 = .001, respectively. 
Further analyses indicated that performance in the target-present condition was indeed better 
in the oxytocin compared to the placebo condition, yet revealed a trend towards the converse 
pattern in the target-absent condition, F(1,58) = 4.064, p = .048, ƞp
2 
= .065 and F(1,58) = 
3.311, p = .074, ƞp
2
 = .054, respectively. 
< Insert Figure 1 > 
Third, we analysed sensitivity (d’ identification) and bias (criterion c), to examine 
whether oxytocin improved overall performance or changed participants’ response bias. 
Sensitivity was calculated by combining hits with false-positive scores; bias was calculated 
by combining all positive responses across both trial types (hits, misidentifications, and false-
positives: Macmillan & Creelman, 2005
1
). A univariate ANOVA on each measure revealed 
that oxytocin did not improve overall performance (oxytocin d’: M = 0.71, SE = 0.15; 
placebo d’: M = 0.69, SE = 0.15), F(1,58) = .005, p = .946, ƞp
2
 = .001, but participants in the 
oxytocin condition (c = -0.61, SE = .08) showed a more liberal response bias (i.e., more 
positive responses) than participants in the placebo condition (c = -0.22, SE = .08), F(1,58) = 
11.83, p = .001, ƞp
2
 = .169. This pattern of results indicates that, compared to placebo 
participants, those in the oxytocin condition were more likely to say that the target face was 
present in a line-up, but were no more likely to correctly identify it. In other words, the 
oxytocin-induced increase in performance in target-present line-ups revealed in the initial 
analysis can be accounted for by changes in patterns of responding, rather than changes in 
overall accuracy.  
 Fourth, we examined the responses made within the target-present condition. Our 
initial analysis (see Figure 1) established that participants in the oxytocin condition made 
                                                            
1
 See Meissner, Tredoux, Parker, and MacLin (2005) and McQuinton, Malpass, and Tredoux (2006) for rationale 
for the use of signal detection theory in line-up paradigms. 
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fewer errors overall in the target-present condition than those in the placebo condition. 
However, the target-present condition contained two potential sources of error: misses 
(responding “absent”) and misidentifications (selecting the incorrect face). To examine 
whether oxytocin affected the pattern of responding, rather than reducing errors more 
generally, the proportion of misidentifications and misses were calculated for each 
participant. A univariate ANOVA indicated that oxytocin participants made more 
misidentification errors, whereas placebo participants made more misses, F(1,58) = 10.067, p 
= .002, ƞp
2 
= .148 (see Figure 2). We also examined whether participants who correctly 
identified that a face was present were more likely to correctly identify the individual face, by 
calculating the proportion of hits and misidentifications within the target present trials. A 
univariate ANOVA indicated that the proportion of hits and misidentifications did not differ 
between the oxytocin (M = 0.80, SE = 0.03) and placebo (M = 0.81, SE = 0.03) conditions, 
F(1,58) = 0.064, p = .800. 
< Insert Figure 2 > 
 Finally, a mixed factorial MANOVA examined the MMQ scores and revealed a main 
effect of time, F(6,53) = 5.103, p = .001, ƞp
2
 = .366. Specifically, regardless of spray, 
participants felt less “good”, “awake”, and “nervous” at the end of the testing session: 
F(2,116) = 4.698, p = .016, ƞp
2
 = .075, F(2,116) = 9.065, p = .001, ƞp
2
 = .135, and F(2,116) = 
4.939, p = .015, ƞp
2
 = .078, respectively. No main effect of spray or interaction between time 
and spray was observed, F(3,56) = .393, p = .759, ƞp
2
 = .021 and F(6,53) = .884, p = .513, ƞp
2
 
= .091, respectively, indicating that the findings cannot be attributed to potential mood-
altering effects of oxytocin. 
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DISCUSSION 
 
This study investigated the effect of oxytocin on face recognition performance in target-
present and target-absent line-ups. Compared to a placebo condition, oxytocin did not 
improve overall accuracy, but facilitated performance in target-present line-ups and 
somewhat impeded performance in target-absent trials. When participants did make errors in 
target-present trials, those in the oxytocin condition were more likely to make 
misidentification errors (responding “present” but selecting the wrong face) than misses 
(responding “absent”). In other words, participants in the oxytocin condition showed a 
general increase in bias to respond “present”. However, this was not matched by an increase 
in identification of the target face: for target-present trials on which the participant responded 
“present”, participants showed the same proportion of hits and misidentifications under 
oxytocin and placebo conditions. This pattern of results could not be accounted for by a 
speed-accuracy trade-off or changes in mood or arousal.  
These findings argue against the hypothesis that oxytocin acts directly on 
visuocognitive mechanisms within the face-processing system. Although previous work 
found an increase in face recognition performance after oxytocin inhalation (e.g., Rimmele et 
al., 2009; Guastella et al., 2008), this is the first study to link oxytocin with a more liberal 
response bias – Blandón-Gitlin and colleagues (in press) and Saskavan et al. (2008) found a 
more conservative pattern of responding under oxytocin conditions. However, previous 
studies have generally examined the influence of oxytocin on face memory as opposed to 
face-matching, such that oxytocin is administered prior to or just after encoding, and 
recognition is tested in a later session. The factors that could make oxytocin beneficial for 
face encoding (i.e. increased attention to socially salient elements of the face) could be 
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detrimental in matching tasks: if oxytocin increased the salience of all the line-up faces, 
participants could have mistaken this salience for familiarity, leading to false- positive errors.  
Further, the format of the test may explain these differences in findings. Previous 
work has almost exclusively used old/new tests, and a line-up may have prompted alternative 
decision strategies. Specifically, participants in the oxytocin condition may resort to a “next 
best” choice when the target is absent, whereas participants in the placebo condition may 
judge each face on a match/no match criteria (analogous to proposed strategies used in 
simultaneous and sequential eyewitness line-ups, see Leach, Cutler, & Van Wallendael, 
2009). Currently, though, it is unclear what mechanisms could support this strategy shift, and 
how they relate to the neural networks affected by oxytocin. As such, it is more likely that the 
results of the current study are mediated by changes in social salience, rather than changes in 
decision strategy.  
While the current study focussed on facial identity processing, the findings have 
implications for our understanding of the effects of oxytocin on facial emotion processing. As 
mentioned in the introduction, many studies have found improved facial emotion recognition 
following inhalation of oxytocin (Van Ijzendoorn & Bakermans-Kranenburg, 2012). Previous 
studies have occasionally attributed this improvement to emotion-specific mechanisms, such 
as stronger encoding of positive social stimuli (Guastella et al., 2008; Marsh et al., 2010), or a 
reduction in anxiety or aversion in response to negative social stimuli (Campbell, 2010). 
However, the fact that the effects of oxytocin extend to neutral faces, as in the current study 
(see also Bate et al., 2014; Saskavan et al., 2008), suggests that the effects of oxytocin are not 
limited to emotional faces. Note this does not rule out the possibility that emotional faces 
might elicit a larger effect of oxytocin, or that oxytocin might have variable effects depending 
on the perceived emotion (particularly if the emotions are associated with approach or 
withdrawal behaviours, Kemp & Guastella, 2011). Our results simply suggest that the effects 
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of oxytocin are not unique to emotional faces – once again, this supports the hypothesis that 
oxytocin acts to increase the salience of socially relevant stimuli in the environment. 
It is interesting to note that there were no effects of gender on any of the measures in 
the present study, particularly as there is a substantial body of literature that has found 
different neural effects of oxytocin in women and men (e.g., Domes et al., 2007, 2010; see 
Kanat, Heinrichs, & Domes, in press). However, this is not inconsistent with previous studies 
investigating the behavioural effects of oxytocin on face-processing – the few behavioural 
studies that have used both male and female participants have found no or minimal 
interaction between oxytocin and gender in facial identity processing (Herzmann et al., 2012; 
Saskavan et al., 2008) and facial emotion processing (Marsh et al., 2010). Nonetheless, future 
research should continue to investigate the interaction between oxytocin and gender, to 
clarify the links between the neural and behavioural effects of oxytocin. While we did not 
find any overall effects of gender, it is possible that factors such as intake of oral 
contraceptives and the phase of female participants’ menstrual cycle may have influenced 
results within the female subsample, as these factors can contribute to variations in plasma 
oxytocin levels (Silber et al., 1987; Stock, Bremme, & Uvnäs-Moberg, 1991) and potentially 
alter the effects of exogenous oxytocin. The current study did not monitor these variables, 
however, future studies may wish to take these factors into account when investigating the 
effects of oxytocin on face-processing in females.  
In sum, this study adds to the growing body of evidence that intranasal inhalation of 
oxytocin is not universally beneficial for social cognition (Bartz et al., 2011). While oxytocin 
may improve face recognition under some circumstances, there is no discernable benefit of 
oxytocin in a face-matching task using line-up arrays. Currently, it is unclear which factor 
resulted in the increased bias observed in the current study. Further research with simple 
face-matching tasks, face memory tasks using line-ups, and oxytocin inhalation before 
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recognition (as opposed to encoding), should clarify when and why oxytocin modulates face 
recognition. This in turn will provide guidance as to whether oxytocin is a viable tool in 
applied face recognition scenarios, such as eyewitness identification. Given oxytocin has 
recently been applied to disorders of face-processing (i.e. to prosopagnosia and autism 
spectrum disorder: Bate et al., 2014; Andari et al., 2010), caution should be exercised in 
further clinical work until the positive and negative effects of the hormone are clearly 
established, and the implications of these effects on real-world situations is fully understood. 
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Table 1: Mean (SD) performance in the One-In-Ten task according to gender.  
 Placebo  Oxytocin 
Gender N Encoding 
time (ms) 
Hits 
(/20) 
MisID
s (/20) 
CRs 
(/20) 
d’ Bias 
(c) 
 N Encoding 
time (ms) 
Hits 
(/20) 
MisID
s (/20) 
CRs 
(/20) 
 d’ Bias 
(c) 
Female 16 10413.12 
(5557.96) 
13.31 
(2.54) 
2.75 
(2.29) 
12.44 
(3.35) 
0.83 
(0.62) 
-0.26 
(0.38) 
 19 8306.98 
(4817.89) 
14.32 
(3.21) 
3.63 
(3.02) 
10.37 
(4.34) 
0.65 
(1.06) 
-0.69 
(0.50) 
Male 14 9190.25 
(4706.99) 
11.79 
(3.83) 
3.14 
(1.51) 
12.50 
(3.41) 
0.56 
(0.70) 
-0.17 
(0.48) 
 11 7154.74 
(3839.29) 
14.00 
(2.37) 
3.27 
(2.19) 
11.36 
(3.53) 
0.76 
(0.73) 
-0.45 
(0.26) 
Total 30 9842.44 
(5127.87) 
12.60 
(3.24) 
2.93 
(1.94) 
12.47 
(3.32) 
0.71 
(0.66) 
-0.22 
(0.42) 
 30 7884.49 
(4450.76) 
14.20 
(2.89) 
3.50 
(2.71) 
10.73 
(4.02) 
0.69 
(0.94) 
-0.61 
(0.43) 
Note: Mean encoding time is for all trials; Hits: Correct identifications in target present trials; MisIDs: Incorrect identifications in target present 
trials; CRs (Correct rejections): “absent” responses in target absent trials; d’: calculated based on Hits and Correct rejections; c: calculated on all 
“present” responses for target present trials (Hits and MisIDs) and target absent trials.  
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FIGURE CAPTIONS 
 
Figure 1: Number of correct responses for target-present and target-absent line-ups, under 
oxytocin and placebo conditions. Error bars represent +/- 1 SEM. ** p < .05; * p < .1. 
 
Figure 2: Proportion of misidentification errors in target-present line-ups, under oxytocin and 
placebo conditions. The remaining errors are misses. Error bars represent +/- 1 SEM. ** p < 
.05. 
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